- Home
- HAS vs PRME Comparison
HAS vs PRME Comparison
Compare HAS & PRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HAS | PRME |
|---|---|---|
| Founded | 1923 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Recreational Games/Products/Toys | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.1B | 666.1M |
| IPO Year | N/A | 2022 |
Fundamental Metrics
Financial Performance| Metric | HAS | PRME |
|---|---|---|
| Price | $82.96 | $3.47 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 11 | 5 |
| Target Price | ★ $88.55 | $6.42 |
| AVG Volume (30 Days) | 1.4M | ★ 3.8M |
| Earning Date | 02-19-2026 | 11-07-2025 |
| Dividend Yield | ★ 3.38% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $4,357,000,000.00 | $5,977,000.00 |
| Revenue This Year | $10.24 | $111.80 |
| Revenue Next Year | $5.62 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 0.79 | ★ 647.13 |
| 52 Week Low | $49.00 | $1.11 |
| 52 Week High | $85.15 | $6.94 |
Technical Indicators
Market Signals| Indicator | HAS | PRME |
|---|---|---|
| Relative Strength Index (RSI) | 59.57 | 41.10 |
| Support Level | $81.00 | $3.29 |
| Resistance Level | $82.98 | $4.12 |
| Average True Range (ATR) | 1.35 | 0.24 |
| MACD | -0.04 | -0.02 |
| Stochastic Oscillator | 66.57 | 17.12 |
Price Performance
Historical ComparisonAbout HAS Hasbro Inc.
Hasbro is a branded play company providing children and families around the world with entertainment offerings based on a world-class brand portfolio. From toys and games to television programming, motion pictures, and a licensing program, Hasbro reaches customers by leveraging its well-known brands such as Transformers, Nerf, and Magic: The Gathering. The firm acquired EOne in 2019, bolting on popular family properties like Peppa Pig and PJ Masks, and since has divested noncore lines from the tie-up. Furthermore, the addition of Dungeons & Dragons Beyond in 2022, offers the firm access to 19 million digital tabletop players.
About PRME Prime Medicine Inc.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.